Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $1.81B.
ENTERPRISE VALUE (EV)
$1.81B
Novavax, Inc.
Market Cap
$1.80B
Enterprise Value (EV)
$1.81B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Novavax, Inc. (NVAX) | $1.80B | $1.81B |
| Xencor, Inc. (XNCR)vs › | $1.80B | $1.82B |
| Generate Biomedicines, Inc. (GENB)vs › | $1.80B | $1.73B |
| Sarepta Therapeutics, Inc. (SRPT)vs › | $1.81B | $2.28B |
| Novocure Ltd (NVCR)vs › | $1.79B | $1.93B |
| LeMaitre Vascular, Inc. (LMAT)vs › | $1.82B | $1.98B |
| Absci Corporation (ABSI)vs › | $1.78B | $1.68B |
| Azenta, Inc. (AZTA)vs › | $1.83B | $1.70B |
| Palvella Therapeutics, Inc. (PVLA)vs › | $1.83B | $1.65B |
| Alignment Healthcare, Inc. (ALHC)vs › | $1.76B | $1.40B |
Market Cap
$1.80B
Total Debt
$244.21M
Cash
$240.63M
Enterprise Value
$1.81B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
